Andolong, Josephine A.

HRN: 28-69-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/15/2026
CIPROFLOXACIN 500MG (TAB)
03/15/2026
03/21/2026
PO
500MG
BID
OBSTRUCTIVE JAUNDICE PROB SEC TO HEPATOBILIARY PATHOLOGY; R/I HEPATITIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: